AKRX Confirms Acquisition Talks, CBIO Plunges, Be All Ears For GERN

Geron Corp. (GERN) is expected to host a conference call on April 10th to provide an update on the ongoing phase II/III trial Imetelstat in myelodysplastic syndromes and the phase II Trial in myelofibrosis.

from RTT - Biotech http://ift.tt/2nYyTWW
via IFTTT